Compositions and methods for enhancing sexual pleasure and performance
Pharmaceutical preparations include at least one component that enhances sexual response and at least one other compound that enhances sexual sensitivity and pleasure. The component that enhances sexual response enhances blood flow to the genital region. Examples include compounds that dilate blood vessels, such as compounds that increase the amount of nitric oxide (NO) in the blood. The component that enhances sexual sensitivity and pleasure includes one or more cannabinoid compounds from the plant genus Cannabis , including extracted compounds, synthetic forms, and derivatives thereof. Examples include tetrahydrocannabinol (THC), the main psychoactive constituent of Cannabis , and cannabidiol (CBD), which is less or non-psychoactive and modulates THC activity. The ratio of THC/CBD can be selected depending on age, gender, physical health, and/or psychological condition of the user.
1. A method of treating sexual dysfunction in a human in need thereof comprising:
a) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a cannabinoid component comprising at least one of tetrahydrocannabinol and cannabidiol;
b) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, and vardenafil; and
c) the cannabinoid component and the sexual response component effectively treating said sexual dysfunction in said human in need thereof.
2. The method of claim 1 , wherein the cannabinoid component contains about 10-500 mg of tetrahydrocannabinol.
3. The method of claim 1 , wherein the cannabinoid component contains about 10-250 mg of tetrahydrocannabinol.
4. The method of claim 1 , wherein the cannabinoid component contains about 10-500 mg of cannabidiol.
5. The method of claim 1 , wherein the cannabinoid component contains about 10-250 mg of cannabidiol.
6. The method of claim 1 , wherein the cannabinoid component comprises tetrahydrocannabinol and/or cannabidiol, and at least one other cannabinoid other than tetrahydrocannabinol and cannabidiol.
7. The method of claim 1 , wherein the cannabinoid component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, infused edibles, infused food preparations, and brownies.
8. The method of claim 1 , wherein the cannabinoid component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
9. The method of claim 1 , wherein the sexual response component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, edibles, and infused food preparations.
10. The method of claim 1 , wherein the sexual response component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
11. The method of claim 1 , wherein said sexual dysfunction is male sexual dysfunction selected from erectile dysfunction, low sexual desire, arousal disorder, and orgasmic disorder.
12. The method of claim 1 , wherein said sexual dysfunction is female sexual dysfunction selected from low sexual desire, arousal disorder, and orgasmic disorder.
13. A method of treating female sexual dysfunction selected from low sexual desire, arousal disorder, and orgasmic disorder in a human in need thereof comprising:
a) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a cannabinoid component comprising at least one of tetrahydrocannabinol and cannabidiol; and
b) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, vardenafil, L-arginine, yohimbe, ginseng, gingko biloba, horny goat weed, and herbal supplements that increase blood flow to the genital region and are not cannabinoids; and
c) the cannabinoid component and the sexual response component effectively treating said female sexual dysfunction in said human in need thereof.
14. The method of claim 13 , wherein the cannabinoid component contains about 10-250 mg of tetrahydrocannabinol and/or about 10-250 mg of cannabidiol.
15. The method of claim 13 , wherein:
the cannabinoid component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, infused edibles, infused food preparations, and brownies; or
the cannabinoid component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
16. The method of claim 13 , wherein:
the sexual response component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, infused edibles, and infused food preparations; or
the sexual response component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
17. A method of treating sexual dysfunction selected from low sexual desire, arousal disorder, and orgasmic disorder in a human in need thereof comprising:
a) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a cannabinoid component comprising at least one of tetrahydrocannabinol and cannabidiol; and
b) administering orally by ingestion which is not smoking or applying topically to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, vardenafil, L-arginine, yohimbe, ginseng, Gingko biloba , horny goat weed, and herbal supplements that increase blood flow to the genital region and are not cannabinoids; and
c) the cannabinoid component and the sexual response component effectively treating said sexual dysfunction in said human in need thereof.
18. The method of claim 17 , wherein:
the cannabinoid component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, infused edibles, infused food preparations, and brownies; or
the cannabinoid component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
19. The method of claim 17 , wherein:
the sexual response component, when administered orally, is a dosage form selected from the group consisting of capsules, tablets, oral drops, edibles, and infused food preparations; or
the sexual response component, when administered topically, is a dosage form selected from the group consisting of massage oil, lotion, gel, cream, lubricant, patch, and suppository.
20. The method of claim 17 , wherein the sexual response component is selected from the group consisting of L-arginine, yohimbe, ginseng, Gingko biloba , horny goat weed, and herbal supplements that increase blood flow to the genital region and are not cannabinoids.
21. The method of claim 20 , wherein the sexual response component is selected from the group consisting of L-arginine, yohimbe, ginseng, gingko biloba, and horny goat weed.